First regenerative treatment in Uruguay with mesenchymal stromal cells of a non-union femoral bone defect in a canine

Authors

  • G. Semiglia Departamento de Pequeños Animales-Perfil Quirúrgico, Facultad de Veterinaria, Universidad de la República, Lasplaces 1620, Montevideo, Uruguay.
  • A. Filomeno Departamento de Pequeños Animales-Perfil Quirúrgico, Facultad de Veterinaria, Universidad de la República, Lasplaces 1620, Montevideo, Uruguay.
  • K. Yaneselli Área de Inmunología, Departamento de Ciencias Microbiológicas, Facultad de Veterinaria, Universidad de la República, Lasplaces 1620, Montevideo, Uruguay.
  • H. Díaz Área de Inmunología, Departamento de Ciencias Microbiológicas, Facultad de Veterinaria, Universidad de la República, Lasplaces 1620, Montevideo, Uruguay.
  • J. Zunino Banco de Tejidos, INDT, Facultad de Medicina, Universidad de la República, Montevideo, Uruguay.
  • U. Benavides Área de Inmunología, Departamento de Ciencias Microbiológicas, Facultad de Veterinaria, Universidad de la República, Lasplaces 1620, Montevideo, Uruguay.
  • J. Maisonnave Área de Inmunología, Departamento de Ciencias Microbiológicas, Facultad de Veterinaria, Universidad de la República, Lasplaces 1620, Montevideo, Uruguay.

Keywords:

Cellular therapy, Non-union, BM - MSC, Canine

Abstract

Non-union is a pathologic bone repair process, where normal conditions of osseous regeneration are altered. The objective of the present study was to assess the alternative treatment of a femoral non-union fracture in a 3 year old male Poodle dog, using bone marrow mesenchymal stromal cells (BM-MSC). After a former conventional surgical treatment of the femoral fracture (open reduction plus external fixation), a non-union was established after two months post-surgery. Thus, a tissue regenerative technique was essayed: percutaneous injection of autologous BM-MSCs at the non-union site. The patient was clinically and radiologically evaluated every 15 days up to 2 months. Observed results seem to demonstrate that the cellular therapy induced bone regeneration starting, two weeks post regenerative treatment. At 8 weeks, clinical and radiological improvement was observed. Cell therapy applied to the femoral non-union enabled bone healing, thus allowing the patient to regain its limb’s function. Further studies are needed to evaluate the application of BM-MSC as an alternative therapy in osseous non-union cases, in order to improve and accelerate the regenerative process in bone lesions.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Published

2014-12-01

How to Cite

Semiglia, G., Filomeno, A., Yaneselli, K., Díaz, H., Zunino, J., Benavides, U., & Maisonnave, J. (2014). First regenerative treatment in Uruguay with mesenchymal stromal cells of a non-union femoral bone defect in a canine. Veterinaria (Montevideo), 50(196), 65–77. Retrieved from https://revistasmvu.com.uy/index.php/smvu/article/view/135

Issue

Section

Technical Notes